Lexicon Pharmaceuticals
LXRX
#6851
Rank
ยฃ0.56 B
Marketcap
ยฃ1.27
Share price
-4.55%
Change (1 day)
13.62%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -ยฃ45.8 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ41.46 Million. In 2025 the company made an earning of -ยฃ38.05 Million, an increase over its 2024 earnings that were of -ยฃ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ45.8 Million20.39%
2025 -ยฃ38.05 Million-74.88%
2024 -ยฃ0.16 Billion13.15%
2023 -ยฃ0.14 Billion73.74%
2022 -ยฃ77.04 Million16.16%
2021 -ยฃ66.32 Million49.82%
2020 -ยฃ44.27 Million-147.19%
2019 ยฃ93.78 M-203.42%
2018 -ยฃ90.7 Million-15.31%
2017 -ยฃ0.11 Billion0.2%
2016 -ยฃ0.11 Billion2920.7%
2015 -ยฃ3.54 Million-95.33%
2014 -ยฃ75.84 Million-3.61%
2013 -ยฃ78.69 Million-5.52%
2012 -ยฃ83.28 Million-4.17%
2011 -ยฃ86.91 Million15.5%
2010 -ยฃ75.25 Million8.36%
2009 -ยฃ69.44 Million-4.81%
2008 -ยฃ72.95 Million28.79%
2007 -ยฃ56.64 Million35.71%
2006 -ยฃ41.74 Million52.91%
2005 -ยฃ27.3 Million-23.89%
2004 -ยฃ35.86 Million-24.19%
2003 -ยฃ47.3 Million-0.48%
2002 -ยฃ47.53 Million44.12%
2001 -ยฃ32.98 Million23.01%
2000 -ยฃ26.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ5.77 B-12,595.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.87 B-1,998.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.90 B-8,552.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.39 Billion 727.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.18 B-499.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ59.98 M-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ17.57 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.11 B-343.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ12.49 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA